ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Bioqual Inc (PK)

Bioqual Inc (PK) (BIOQ)

72.50
0.00
(0.00%)
Closed June 24 3:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
72.50
Bid
70.00
Ask
79.00
Volume
-
0.00 Day's Range 0.00
59.00 52 Week Range 80.00
Market Cap
Previous Close
72.50
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
499
Shares Outstanding
894,416
Dividend Yield
0.69%
PE Ratio
77.66
Earnings Per Share (EPS)
0.93
Revenue
62.66M
Net Profit
835k

About Bioqual Inc (PK)

Sector
Coml Physical, Biologcl Resh
Industry
Coml Physical, Biologcl Resh
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Bioqual Inc (PK) is listed in the Coml Physical, Biologcl Resh sector of the OTCMarkets with ticker BIOQ. The last closing price for Bioqual (PK) was US$72.50. Over the last year, Bioqual (PK) shares have traded in a share price range of US$ 59.00 to US$ 80.00.

Bioqual (PK) currently has 894,416 shares outstanding. The market capitalization of Bioqual (PK) is US$64.85 million. Bioqual (PK) has a price to earnings ratio (PE ratio) of 77.66.

BIOQ Latest News

No news to show yet.
Period †ChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40072.572.572.592872.5CS
12-4.5-5.84415584416777772.549973.29659319CS
26-5.5-7.0512820512878807038674.04010657CS
520.50.69444444444472805953468.55613009CS
156-8.6-10.604192355181.1108.55751278.34433739CS
26036.75102.79720279735.75108.52859863.42466676CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0
134AUPraise Inc
 0.00
(0.00%)
0
1332Nissui Corporation
 0.00
(0.00%)
0
132AIN Holdings Co Ltd
 0.00
(0.00%)
0
131ACCN Group Corp
 0.00
(0.00%)
0
130AVeritas In Silico Inc
 0.00
(0.00%)
0

BIOQ Discussion

View Posts
AskMuncher AskMuncher 4 years ago
$BIOQ BIOQUAL Presents Financial Results for Fiscal Year 2020 and Declares Dividend
Press Release | 09/15/2020
BIOQUAL ((OTC Pink: BIOQ) (www.bioqual.com):



2020




2019




Revenue

$

46,360,201


$

39,478,079




Income Before Income Tax

$

5,488,938


$

3,709,246




Net Income

$

4,230,938


$

2,830,875




Basic Earnings per Share








of Common Stock

$

4.74


$

3.17


Diluted Earnings per Share








of Common Stock

$

4.73


$

3.17


Weighted Average








Number of Shares Outstanding






For Basic Per Share



893,416




893,416


Weighted Average








Number of Shares Outstanding






For Diluted Earnings Per Share



893,971




893,655

BIOQUAL’s Board of Directors has declared a dividend of $1.10 per share for shareholders of record on September 28, 2020, payable on October 21, 2020. This is the nineteenth dividend declared by BIOQUAL.

Statements herein that are not descriptions of historical facts are forward-looking and subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors including risks relating to the ability to continue to extend current government contracts; the Company’s ability to obtain new government or commercial contracts; continued demand for the use of animal models in scientific research; the Company’s ability to perform under its contracts in accordance with the requirements of the contracts; the actual costs incurred in performing the Company’s contracts and its ability to manage its costs, including its capital expenditures; dependence on third parties; future capital needs; the ability to fund its capital needs through the use of its cash on hand and line of credit; and the future availability and cost of financing/capital sources to the Company.


View source version on businesswire.com: https://www.businesswire.com/news/home/20200915005969/en/
👍️0
Ubertino Ubertino 9 years ago
Get on a decent exchange!

Too easily to manipulate as an OTC-Pinky!

Get on a decent exchange - NYSE or affiliate - then I might be interested.
👍️0

Your Recent History

Delayed Upgrade Clock